MEK Inhibition Appears to Improve Symptom Control in Primary NRAS-driven CNS Melanoma in Children

British Journal of Cancer - United Kingdom
doi 10.1038/bjc.2017.49
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

MEK-Inhibition Beim Inoperablen NRAS-mutierten Melanom

hautnah dermatologie
2017English

GAB2 Induces Tumor Angiogenesis in NRAS-driven Melanoma

Oncogene
Cancer ResearchGeneticsMolecular Biology
2012English

645 MIG6 Is MEK-regulated and Affects EGF-induced Migration in Mutant NRAS Melanoma

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2016English

MEK Inhibition Induces Differentiation in RAS-Driven Rhabdomyosarcoma

Cancer Discovery
Oncology
2018English

A Functional Landscape of Resistance to MEK1/2 and CDK4/6 Inhibition in NRAS Mutant Melanoma

Cancer Research
Cancer ResearchOncology
2019English

P2.13-33 a Case Report of Exceptional Clinical Response to MEK Inhibition in a Patient With NRAS Mutation Positive NSCLC

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

JAK Inhibition and Symptom Control in Myeloproliferative Neoplasms

Current Medical Research and Opinion
Medicine
2018English

Autophagy Modulation in MEK Inhibitor-Resistant Melanoma

British Journal of Dermatology
DermatologyMedicine
2019English

Erratum: Mechanism of MEK Inhibition Determines Efficacy in Mutant KRAS- Versus BRAF-driven Cancers

Nature
Multidisciplinary
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy